# Butler National Corp: financial statements, quarterly

BUKS · OTC · CIK 15847 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/buks.md) · [Financials](/companies/buks/financials.md) · [Filings](/companies/buks/filings.md) · [Insiders](/companies/buks/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/buks/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [19.6](/filings/0001437749-24-036821.md) | [19.0](/filings/0001437749-25-007631.md) | [22.6 d](/filings/0001628280-25-034206.md) | [19.8](/filings/0000015847-25-000006.md) | [21.4](/filings/0000015847-25-000021.md) | [21.2](/filings/0000015847-26-000003.md) | [21.6 d](/filings/0000015847-26-000020.md) | [20.1](/filings/0000015847-26-000042.md) | [23.3](/filings/0000015847-25-000021.md) | [26.9](/filings/0000015847-26-000003.md) | [27.7 d](/filings/0000015847-26-000020.md) | [30.8](/filings/0000015847-26-000042.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [0.2 d](/filings/0001437749-24-036821.md) | [1.8 d](/filings/0001437749-25-007631.md) | [(1.4) d](/filings/0001628280-25-034206.md) | [0.2](/filings/0000015847-25-000006.md) | [0.5 d](/filings/0000015847-25-000021.md) | [0.9 d](/filings/0000015847-26-000003.md) | [(0.6) d](/filings/0000015847-26-000020.md) | [0.3](/filings/0000015847-26-000042.md) | [0.3 d](/filings/0000015847-25-000021.md) | [0.5 d](/filings/0000015847-26-000003.md) | [0.4 d](/filings/0000015847-26-000020.md) | [0.3](/filings/0000015847-26-000042.md) |
| Operating income | $m | [3.6](/filings/0001437749-24-036821.md) | [3.8](/filings/0001437749-25-007631.md) | [4.7 d](/filings/0001628280-25-034206.md) | [3.5](/filings/0000015847-25-000006.md) | [4.9](/filings/0000015847-25-000021.md) | [4.0](/filings/0000015847-26-000003.md) | [4.4 d](/filings/0000015847-26-000020.md) | [4.7](/filings/0000015847-26-000042.md) | [7.1](/filings/0000015847-25-000021.md) | [9.2](/filings/0000015847-26-000003.md) | [7.5 d](/filings/0000015847-26-000020.md) | [7.4](/filings/0000015847-26-000042.md) |
| Interest expense | $m | [0.6](/filings/0001437749-24-036821.md) | [0.6](/filings/0001437749-25-007631.md) | [0.6 d](/filings/0001628280-25-034206.md) | [0.6](/filings/0001437749-24-029093.md) | [0.5](/filings/0000015847-25-000021.md) | [0.6](/filings/0000015847-26-000003.md) | [0.5 d](/filings/0000015847-26-000020.md) | [0.5](/filings/0000015847-26-000042.md) | [0.5](/filings/0000015847-25-000021.md) | [0.5](/filings/0000015847-26-000003.md) | [0.4 d](/filings/0000015847-26-000020.md) | [0.4](/filings/0000015847-26-000042.md) |
| Income tax | $m | not reported | not reported | not reported | [0.8](/filings/0000015847-25-000006.md) | [1.3](/filings/0000015847-25-000021.md) | [1.3](/filings/0000015847-26-000003.md) | [0.8 d](/filings/0000015847-26-000020.md) | [0.6](/filings/0000015847-26-000042.md) | [2.8](/filings/0000015847-25-000021.md) | [2.3](/filings/0000015847-26-000003.md) | [1.7 d](/filings/0000015847-26-000020.md) | [1.9](/filings/0000015847-26-000042.md) |
| Net income | $m | [5.0](/filings/0001437749-24-036821.md) | [2.4](/filings/0001437749-25-007631.md) | [4.5 d](/filings/0001628280-25-034206.md) | [2.2](/filings/0000015847-26-000003.md) | [3.6](/filings/0000015847-26-000003.md) | [3.4](/filings/0000015847-26-000003.md) | [3.3 d](/filings/0000015847-26-000020.md) | [3.7](/filings/0000015847-26-000042.md) | [6.0](/filings/0000015847-26-000003.md) | [6.7](/filings/0000015847-26-000003.md) | [5.6 d](/filings/0000015847-26-000020.md) | [5.3](/filings/0000015847-26-000042.md) |
| Diluted EPS | $ per share | [0.07](/filings/0001437749-24-036821.md) | [0.03](/filings/0001437749-25-007631.md) | not reported | [0.03](/filings/0000015847-25-000006.md) | [0.05](/filings/0000015847-25-000021.md) | [0.05](/filings/0000015847-26-000003.md) | not reported | [0.06](/filings/0000015847-26-000042.md) | [0.09](/filings/0000015847-25-000021.md) | [0.10](/filings/0000015847-26-000003.md) | not reported | [0.08](/filings/0000015847-26-000042.md) |
| Basic EPS | $ per share | [0.07](/filings/0001437749-24-036821.md) | [0.03](/filings/0001437749-25-007631.md) | not reported | [0.03](/filings/0000015847-25-000006.md) | [0.05](/filings/0000015847-25-000021.md) | [0.05](/filings/0000015847-26-000003.md) | not reported | [0.06](/filings/0000015847-26-000042.md) | [0.09](/filings/0000015847-25-000021.md) | [0.10](/filings/0000015847-26-000003.md) | not reported | [0.08](/filings/0000015847-26-000042.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [18.3](/filings/0001437749-23-034494.md) | [17.9](/filings/0001437749-24-007949.md) | [17.8](/filings/0001628280-25-034206.md) | [17.8](/filings/0001437749-24-029093.md) | [16.2](/filings/0001437749-24-036821.md) | [30.7](/filings/0001437749-25-007631.md) | [25.2](/filings/0000015847-26-000020.md) | [33.4](/filings/0000015847-25-000006.md) | [29.6](/filings/0000015847-25-000021.md) | [36.5](/filings/0000015847-26-000003.md) | [35.1](/filings/0000015847-26-000042.md) | [35.3](/filings/0000015847-26-000042.md) |
| Current assets | $m | [36.8](/filings/0001437749-23-034494.md) | [38.8](/filings/0001437749-24-007949.md) | [38.6](/filings/0001628280-25-034206.md) | [39.0](/filings/0001437749-24-029093.md) | [37.8](/filings/0001437749-24-036821.md) | [52.7](/filings/0001437749-25-007631.md) | [47.3](/filings/0000015847-26-000020.md) | [54.5](/filings/0000015847-25-000006.md) | [53.1](/filings/0000015847-25-000021.md) | [66.4](/filings/0000015847-26-000003.md) | [67.3](/filings/0000015847-26-000042.md) | [64.8](/filings/0000015847-26-000042.md) |
| Total assets | $m | [112](/filings/0001437749-23-034494.md) | [113](/filings/0001437749-24-007949.md) | [114](/filings/0001628280-25-034206.md) | [115](/filings/0001437749-24-029093.md) | [114](/filings/0001437749-24-036821.md) | [129](/filings/0001437749-25-007631.md) | [123](/filings/0000015847-26-000020.md) | [130](/filings/0000015847-25-000006.md) | [128](/filings/0000015847-25-000021.md) | [141](/filings/0000015847-26-000003.md) | [142](/filings/0000015847-26-000042.md) | [140](/filings/0000015847-26-000042.md) |
| Current liabilities | $m | [24.8](/filings/0001437749-23-034494.md) | [25.2](/filings/0001437749-24-007949.md) | [22.9](/filings/0001628280-25-034206.md) | [22.4](/filings/0001437749-24-029093.md) | [20.6](/filings/0001437749-24-036821.md) | [31.1](/filings/0001437749-25-007631.md) | [24.4](/filings/0000015847-26-000020.md) | [32.6](/filings/0000015847-25-000006.md) | [27.1](/filings/0000015847-25-000021.md) | [35.2](/filings/0000015847-26-000003.md) | [31.4](/filings/0000015847-26-000042.md) | [25.8](/filings/0000015847-26-000042.md) |
| Total liabilities | $m | [64.1](/filings/0001437749-23-034494.md) | [63.4](/filings/0001437749-24-007949.md) | [59.5](/filings/0001628280-25-034206.md) | [58.4](/filings/0001437749-24-029093.md) | [55.3](/filings/0001437749-24-036821.md) | [66.2](/filings/0001437749-25-007631.md) | [58.2](/filings/0000015847-26-000020.md) | [65.0](/filings/0000015847-25-000006.md) | [58.0](/filings/0000015847-25-000021.md) | [64.6](/filings/0000015847-26-000003.md) | [59.9](/filings/0000015847-26-000042.md) | [53.2](/filings/0000015847-26-000042.md) |
| Long-term debt | $m | [36.0](/filings/0001437749-23-034494.md) | [34.8](/filings/0001437749-24-007949.md) | [33.2](/filings/0001628280-25-034206.md) | [32.0](/filings/0001437749-24-029093.md) | [30.7](/filings/0001437749-24-036821.md) | [31.2](/filings/0001437749-25-007631.md) | [29.9](/filings/0000015847-26-000020.md) | [28.5](/filings/0000015847-25-000006.md) | [27.0](/filings/0000015847-25-000021.md) | [25.6](/filings/0000015847-26-000003.md) | [24.6](/filings/0000015847-26-000042.md) | [23.6](/filings/0000015847-26-000042.md) |
| Current portion of debt | $m | [4.9](/filings/0001437749-23-034494.md) | [4.9](/filings/0001437749-24-007949.md) | [4.9](/filings/0001628280-25-034206.md) | [4.9](/filings/0001437749-24-029093.md) | [5.0](/filings/0001437749-24-036821.md) | [5.2](/filings/0001437749-25-007631.md) | [5.3](/filings/0000015847-26-000020.md) | [5.3](/filings/0000015847-25-000006.md) | [5.4](/filings/0000015847-25-000021.md) | [5.2](/filings/0000015847-26-000003.md) | [4.9](/filings/0000015847-26-000042.md) | [4.4](/filings/0000015847-26-000042.md) |
| Shareholders' equity | $m | [47.5](/filings/0001437749-23-034494.md) | [49.9](/filings/0001437749-24-007949.md) | [54.4](/filings/0000015847-26-000020.md) | [56.3](/filings/0000015847-26-000003.md) | [59.1](/filings/0000015847-26-000003.md) | [62.4](/filings/0000015847-26-000003.md) | [65.1](/filings/0000015847-26-000042.md) | [65.2](/filings/0000015847-26-000042.md) | [70.2](/filings/0000015847-26-000003.md) | [76.3](/filings/0000015847-26-000003.md) | [82.0](/filings/0000015847-26-000042.md) | [86.3](/filings/0000015847-26-000042.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.3 d](/filings/0001437749-24-036821.md) | [2.1 d](/filings/0001437749-25-007631.md) | [2.0 d](/filings/0001628280-25-034206.md) | [3.0](/filings/0000015847-25-000006.md) | [2.6 d](/filings/0000015847-25-000021.md) | [14.0 d](/filings/0000015847-26-000003.md) | [(1.2) d](/filings/0000015847-26-000020.md) | [14.7](/filings/0000015847-26-000042.md) | [(0.8) d](/filings/0000015847-25-000021.md) | [10.6 d](/filings/0000015847-26-000003.md) | [1.3 d](/filings/0000015847-26-000020.md) | [4.6](/filings/0000015847-26-000042.md) |
| Capital expenditure | $m | [3.5 d](/filings/0001437749-24-036821.md) | [1.2 d](/filings/0001437749-25-007631.md) | [3.2 d](/filings/0001628280-25-034206.md) | [1.2](/filings/0000015847-25-000006.md) | [3.4 d](/filings/0000015847-25-000021.md) | [1.5 d](/filings/0000015847-26-000003.md) | [2.1 d](/filings/0000015847-26-000020.md) | [1.4](/filings/0000015847-26-000042.md) | [1.9 d](/filings/0000015847-25-000021.md) | [1.5 d](/filings/0000015847-26-000003.md) | [1.8 d](/filings/0000015847-26-000020.md) | [1.9](/filings/0000015847-26-000042.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-036821.md) | [0.0 d](/filings/0001437749-25-007631.md) | [0.0 d](/filings/0001628280-25-034206.md) | [0.5](/filings/0000015847-25-000006.md) | [0.9 d](/filings/0000015847-25-000021.md) | [0.1 d](/filings/0000015847-26-000003.md) | [0.8 d](/filings/0000015847-26-000020.md) | [3.7](/filings/0000015847-25-000006.md) | [1.2 d](/filings/0000015847-25-000021.md) | [0.7 d](/filings/0000015847-26-000003.md) | [0.0 d](/filings/0000015847-26-000020.md) | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-10-31) | Q3 FY2023 (2023-01-31) | Q1 FY2024 (2023-07-31) | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [76.8](/filings/0001437749-23-034494.md) | [76.7](/filings/0001437749-24-007949.md) | [75.2](/filings/0001437749-24-029093.md) | [69.5](/filings/0001437749-24-036821.md) | [69.6](/filings/0001437749-25-007631.md) | [68.7](/filings/0000015847-25-000006.md) | [68.0](/filings/0000015847-25-000021.md) | [67.0](/filings/0000015847-26-000003.md) | [66.9](/filings/0000015847-26-000042.md) | [64.6](/filings/0000015847-25-000021.md) | [64.2](/filings/0000015847-26-000003.md) | [64.0](/filings/0000015847-26-000042.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 63,842,119 at 2026-09-11, from the cover of the [10-Q filed 2026-09-11](/filings/0000015847-26-000042.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.